Generation Bio Co (NAS:GBIO)
$ 2.64 -0.13 (-4.69%) Market Cap: 176.20 Mil Enterprise Value: 53.21 Mil PE Ratio: 0 PB Ratio: 1.61 GF Score: 34/100

Generation Bio Co R&D Deep Dive Transcript

Nov 01, 2023 / 04:00PM GMT
Release Date Price: $0.9751 (+3.92%)
Geoff McDonough
Generation Bio Co. - President & CEO

It's really a pleasure to bring together two discoveries which had the chance to announce over the last couple of weeks around immune-quiet DNA. On the one hand, a novel cargo, which can leverage a broad set of delivery options on the one hand; and on the other, a unique cell targeted lipid nanoparticle delivery system, a new delivery system, which can leverage multiple cargoes.

The opportunity today is for us to give you the full voiceover of two presentations around these technologies that were given in close scientific settings. And today is an opportunity for you to hear the full voiceover behind these presentations as well as to put the depth of the investments that we've made in our platform into context over the next several presentations.

So Generation Bio is bringing DNA to non-viral genetic medicines. And writing the next chapter of non-viral genetic medicines really depends on the strength and depth of the preceding work. And those first chapters of non-viral genetic medicine have been written in RNA. Beginning with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot